"Mesoblast is in advanced negotiations with selected pharmaceutical companies with respect to
potential partnering of certain Tier 1 product candidates. If Mesoblast enters into a binding
transaction in the next quarter, it expects that one effect of the transaction is that its cash reserves
are likely to increase. Mesoblast does not make any representation or give any assurance that
such a binding transaction will be concluded."
The CEO that cried wolf.
Ann: Appendix 4C - quarterly, page-2
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
0.030(1.90%) |
Mkt cap ! $1.832B | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.65 | $1.59 | $7.014M | 4.343M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 342 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 54534 | 8 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |